ID
24054
Beschrijving
Comparison of Biphasic Insulin Aspart 30 Versus Insulin Glargine Both in Combination With Metformin and Glimepiride in Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00469092
Link
https://clinicaltrials.gov/show/NCT00469092
Trefwoorden
Versies (1)
- 24-07-17 24-07-17 -
Geüploaded op
24 juli 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Diabetes NCT00469092
Eligibility Diabetes NCT00469092
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Medical contraindication Metformin
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1301624
- UMLS CUI [1,2]
- C0025598
Beschrijving
Thiazolidinediones
Datatype
boolean
Alias
- UMLS CUI [1]
- C1257987
Beschrijving
Systemic Corticosteroid Therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C4053960
Beschrijving
Disease Interferes with Clinical Trial | Condition Interferes with Clinical Trial
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0012634
- UMLS CUI [1,2]
- C0521102
- UMLS CUI [1,3]
- C0008976
- UMLS CUI [2,1]
- C0348080
- UMLS CUI [2,2]
- C0521102
- UMLS CUI [2,3]
- C0008976
Similar models
Eligibility Diabetes NCT00469092
- StudyEvent: Eligibility
C1527415 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,2])
C1283071 (UMLS CUI [1,3])
C0178602 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0919936 (UMLS CUI [1,2])
C0025598 (UMLS CUI [1,2])
C0521102 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0348080 (UMLS CUI [2,1])
C0521102 (UMLS CUI [2,2])
C0008976 (UMLS CUI [2,3])